In summary, these findings suggest that BCR-ABL1+ and BCR-ABL1T315I+ leukemia cells differ with respect to homing localization in the BMM, migration, adhesion, disease aggressiveness and (immuno-) phenotype. Here, BCR is linked to leukemia.